We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$252B
AUM Growth
-$7.74B
Cap. Flow
-$10.2B
Cap. Flow %
-4.03%
Top 10 Hldgs %
22.68%
Holding
10,737
New
1,370
Increased
3,710
Reduced
4,352
Closed
1,178

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Consumer Discretionary 2.02%
3 Financials 1.63%
4 Healthcare 1.38%
5 Energy 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTR
9376
PUT
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$38K ﹤0.01%
15,100
-8,400
-36% -$20.4K
LEE icon
9377
PUT
Lee Enterprises
LEE
$185M
$37K ﹤0.01%
1,000
PLUR icon
9378
CALL
Pluri
PLUR
$17.2M
$37K ﹤0.01%
186
-30
-14% -$6.52K
PKD
9379
PUT
DELISTED
Parker Drilling Company
PKD
$37K ﹤0.01%
+793
New +$46.1K
GAZ
9380
DELISTED
iPath Bloomberg Natural Gas Subindex Total Return ETN due October 22, 2037
GAZ
$37K ﹤0.01%
18,336
-18,195
-50% -$42.8K
ROSG
9381
PUT
DELISTED
Rosetta Genomics Ltd.
ROSG
$37K ﹤0.01%
1,350
-3,733
-73% -$121K
CRWN
9382
DELISTED
CROWN MEDIA HOLDINGS INC CL-A
CRWN
$37K ﹤0.01%
+10,319
New +$35K
LIVE icon
9383
CALL
Live Ventures
LIVE
$28.9M
$36K ﹤0.01%
+1,917
New +$33.7K
FLNA
9384
CALL
Filana Therapeutics
FLNA
$44.7M
$36K ﹤0.01%
2,543
-3,028
-54% -$52.4K
IRD
9385
Opus Genetics
IRD
$328M
$36K ﹤0.01%
+107
New +$36.9K
AXU
9386
CALL
DELISTED
Alexco Resource Corp
AXU
$36K ﹤0.01%
69,100
-500
-0.7% -$273
SPRT
9387
DELISTED
support.com, Inc.
SPRT
$36K ﹤0.01%
5,705
-469
-8% -$2.93K
ANTH
9388
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$36K ﹤0.01%
2,866
-10,557
-79% -$153K
MVIS icon
9389
CALL
Microvision
MVIS
$56M
$35K ﹤0.01%
1,353
-4,560
-77% -$121K
ZGNX
9390
CALL
DELISTED
Zogenix, Inc.
ZGNX
$35K ﹤0.01%
3,225
-1,438
-31% -$14.2K
NADL
9391
PUT
DELISTED
North Atlantic Drilling Ltd
NADL
$35K ﹤0.01%
2,170
-5,500
-72% -$219K
HYF
9392
DELISTED
MANAGED HIGH YLD PLUS FD INC
HYF
$35K ﹤0.01%
+19,500
New +$38.1K
MPO
9393
PUT
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
$35K ﹤0.01%
2,340
-19,760
-89% -$520K
AXTI icon
9394
AXT Inc
AXTI
$4.28B
$34K ﹤0.01%
12,147
-129,925
-91% -$320K
OPTT icon
9395
Ocean Power Technologies
OPTT
$46M
$34K ﹤0.01%
+265
New +$50.8K
ZN
9396
DELISTED
Zion Oil & Gas, Inc.
ZN
$34K ﹤0.01%
24,478
-2,588
-10% -$4.16K
ROSG
9397
DELISTED
Rosetta Genomics Ltd.
ROSG
$34K ﹤0.01%
1,255
-3,125
-71% -$101K
ALSK
9398
DELISTED
Alaska Communications Systems
ALSK
$33K ﹤0.01%
18,275
-17,437
-49% -$26.1K
INSG icon
9399
PUT
Inseego
INSG
$74.4M
$32K ﹤0.01%
1,000
-3,050
-75% -$93.8K
OMEX icon
9400
PUT
Odyssey Marine Exploration
OMEX
$53.6M
$32K ﹤0.01%
2,875
+1,817
+172% +$23.1K

Similar funds

Jeff Yass's Q4 2014 Portfolio in Review

As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jeff Yass withdrew a net $10.2B in Q4 2014, closing 1,178 positions and reducing 4,352 holdings. Its most notable exit was Bausch Health, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in Northern Trust Morningstar Global Upstream Natural Resources ETF worth $31M.

  • Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
  • Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
  • Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
  • Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
  • Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
  • Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.

Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.